Before Patrick Daly was tapped as chairman of AdvaMed’s Accel unit, which represents emerging medical device companies, the CEO of Cohera Medical sat down with MassDevice.com Executive Editor Brad Perriello at DeviceTalks Raleigh.
Daly, who founded the absorbable surgical adhesives and sealants company in 2006, has led 4 funding rounds totaling $75M in capital and brought Cohera Medical’s 1st product, TissuGlu, through the FDA’s stringent pre-market approval process. A 2nd product, Sylys, was the 1st medical device selected for the federal watchdog agency’s Expedited Access Protocol for breakthrough products.
Daly told us how he raised 1 of the largest seed rounds in history, why he’s moving the company to Raleigh, N.C., and how some tough days have led to many laps around the block before pulling in to the driveway.
This episode was recorded Feb. 29, 2016, at our DeviceTalks Raleigh event. To learn more about our DeviceTalks show and how you can attend a live taping, click here.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!